300111SZSE

2025 Annual Financial Report

✨ AI Summary

This report presents the 2025 financial results for Zhejiang Sunflower Health Technology Co., Ltd., audited by Lixin Certified Public Accountants. The company experienced a revenue decrease of 17.81% and a net loss attributable to shareholders of RMB 4.38 million. Total assets slightly decreased by 1.49% to RMB 984 million, while total liabilities and owner's equity also saw a minor decrease.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Zhejiang Sunflower Health Technology Co., Ltd. 2025 Annual Financial Report

Zhejiang Sunflower Health Technology Co., Ltd. (hereinafter referred to as the "Company" or "Sunflower") financial statements were audited by Lixin Certified Public Accountants (Special General Partnership), which issued a standard unqualified audit report [Xin Hui Shi Bao Zi [2026] No. ZF10315]. The auditor's opinion is that the Company's financial statements are prepared in all material respects in accordance with the requirements of the Accounting Standards for Business Enterprises, and fairly reflect the consolidated and parent company's financial position as of December 31, 2025, and the consolidated and parent company's operating results and cash flows for 2025.

I. Overview of 2025 Financial Position

20252024Year-on-year increase/decrease2023
Operating Revenue (RMB)271,534,667.17330,368,712.17-17.81%338,419,251.07
Net Profit Attributable to Shareholders of Listed Companies (RMB)-4,384,751.457,827,252.98-156.02%21,747,861.40
Net Profit Attributable to Shareholders of Listed Companies, Excluding Non-recurring Gains and Losses (RMB)-4,629,937.016,263,678.83-173.92%-15,689,777.70
Net Cash Flow from Operating Activities (RMB)4,197,351.3731,436,632.22-86.65%2,869,789.87
Basic Earnings Per Share (RMB/share)-0.0030.006-150.00%0.017
Diluted Earnings Per Share (RMB/share)-0.0030.006-150.00%0.017
Weighted Average Return on Equity-0.64%1.15%-1.79%3.59%
As of Year-end 2025As of Year-end 2024Year-on-year increase/decreaseAs of Year-end 2023
Total Assets (RMB)984,182,324.89999,118,426.12-1.49%1,242,046,575.23
Net Assets Attributable to Shareholders of Listed Companies (RMB)682,027,032.17686,244,996.62-0.61%678,325,719.64

II. Asset Situation

Unit: RMB

AssetAs of December 31, 2025As of December 31, 2024Change Rate
Cash and Cash Equivalents504,867,988.61567,369,613.62-11.02%
Notes Receivable787,500.002,860,000.00-72.47%
Accounts Receivable46,411,616.7467,979,049.18-31.73%
Contract Assets18,402,202.602,974,976.82518.57%
Prepayments757,213.201,042,598.88-27.37%
Other Receivables44,152,579.52126,719.0634,742.89%
Inventory170,582,567.98142,833,425.1319.43%
Other Current Assets2,410,797.732,711,880.68-11.10%
Total Current Assets788,372,466.38787,898,263.370.06%
Investments in Debt Instruments51,720,069.4450,528,750.002.36%
Investments in Equity Instruments822,785.00655,998.0025.42%
Property, Plant and Equipment64,741,487.2676,444,775.45-15.31%
Construction in Progress13,937,350.0018,804,120.30-25.88%
Right-of-Use Assets0.00720,574.39-100.00%
Intangible Assets44,260,060.1247,311,718.32-6.45%
Development Expenses13,271,570.7311,791,242.7912.55%
Long-term Prepaid Expenses1,283,101.971,896,365.45-32.34%
Deferred Tax Assets3,982,287.502,600,218.0553.15%
Other Non-current Assets1,791,146.49466,400.00284.04%
Total Non-current Assets195,809,858.51211,220,162.75-7.30%
Total Assets984,182,324.89999,118,426.12-1.49%

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.